Stay updated on UCART123 in BPDCN: Safety & Clinical Activity Clinical Trial
Sign up to get notified when there's something new on the UCART123 in BPDCN: Safety & Clinical Activity Clinical Trial page.

Latest updates to the UCART123 in BPDCN: Safety & Clinical Activity Clinical Trial page
- Check2 days agoChange DetectedThe old and new screenshots show largely the same study details with minor layout and formatting differences; core content such as the study title, eligibility criteria, and primary outcome measures appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check9 days agoNo Change Detected
- Check31 days agoChange Detected- Added a government operating-status notice and new version tag (v3.2.0). - Removed a specific resource topic (CD4+/CD56+ hematodermic neoplasm) from Genetic and Rare Diseases Information Center. - Updated revision history from v3.1.0 to v3.2.0.SummaryDifference7%

- Check38 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows Revision: v3.0.2 instead of v3.0.1, indicating a minor release. The previous Revision: v3.0.1 and the Back to Top link were removed.SummaryDifference0.4%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.4%

- Check66 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed classifications of various hematologic and skin-related neoplasms. Notably, the revision version has been updated from v2.16.12 to v3.0.0.SummaryDifference5%

Stay in the know with updates to UCART123 in BPDCN: Safety & Clinical Activity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART123 in BPDCN: Safety & Clinical Activity Clinical Trial page.